Advertisement

Topics

Emisphere Technologies Inc EMIS Strategic SWOT Analysis Review [Report Updated: 05122018] Prices from USD $125

11:46 EST 16 Dec 2018 | BioPortfolio Reports

Emisphere Technologies Inc EMIS Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.


This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Scope


Business description A detailed description of the company's operations and business divisions.

Corporate strategy GlobalData's summarization of the company's business strategy.

SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities A list of key manufacturing facilities of the company.


Highlights


Emisphere Technologies Inc Emisphere is a specialty pharmaceutical and drug delivery company. The company in partnership with global pharmaceutical companies develops novel oral formulations of existing injectable biopharmaceutical products, besides new chemical entities, using its Eligen technology. Its lead product Eligen B12, is the first and only oncedaily oral prescription medical food approved in the US for treatment of vitamin B12 deficiency. The product is sold through distributors, sellers and other sources. Emisphere also uses its proprietary Eligen technology to produce novel oral formulations of therapeutic agents. Emisphere is headquartered in Roseland, New Jersey, the US.


Emisphere Technologies Inc Key Recent Developments


May 12,2017: Emisphere Reports First Quarter 2017 Financial Results

Mar 29,2017: Emisphere Reports Fourth Quarter and Full Year 2016 Financial Results


Reasons to Buy


Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.


Note: Some sections may be missing if data is unavailable for the company.

Original Article: Emisphere Technologies Inc EMIS Strategic SWOT Analysis Review [Report Updated: 05122018] Prices from USD $125

NEXT ARTICLE

More From BioPortfolio on "Emisphere Technologies Inc EMIS Strategic SWOT Analysis Review [Report Updated: 05122018] Prices from USD $125"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...